Drug DrugBank | All Description Patterns💬 Info on mouse-over
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY On map, Yellow: Drug target genes |
Disease ID |
1 | Bmn 110 | - | - | - | - | 019 [1] 19 💬 |
2 | Bmn 110 - every other week | - | - | - | - | 019 [1] 19 💬 |
3 | Bmn 110 - weekly | - | - | - | - | 019 [1] 19 💬 |
4 | Bmn 110 every other week | - | - | - | - | 019 [1] 19 💬 |
5 | Bmn 110 weekly | - | - | - | - | 019 [1] 19 💬 |
6 | Recombinant human n-acetylgalactosamine 6-sulfatase, bmn 110 | - | - | - | - | 019 [1] 19 💬 |
7 | Recombinant human n-acetylgalactosamine 6-sulfatase, bmn 110 drug substance | - | - | - | - | 019 [1] 19 💬 |
8 | Recombinant human n-acetylgalactosamine-6-sulfatase, bmn 110 | Elosulfase alfa | [1] D10333 D10333 💬 |
GALNS [1] GALNS 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [1] 19 💬 |
9 | Recombinant human n-acetylgalactosamine-6-sulfatase, bmn 110 drug substance | Elosulfase alfa | [1] D10333 D10333 💬 |
GALNS [1] GALNS 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [1] 19 💬 |